To use or not to use?
Updated post-market surveillance (PMS) rules for medical devices in the UK: differences from the EU regulations
Reporting clinical trial results to the market
European Court of Justice on advertising for biocidal products: ‘Skin-friendly’ is misleading and violates EU law
Regulatory update: microplastics and medical devices
Labelling requirements for medical devices under the new EU Product Safety Regulation
Medical device manufacturers: control your supply chain for MDR and IVDR requirements
The EU torpedoes itself in cross-border patent disputes
Return to